Novartis AG ADR

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$14,358,000
$14,836,000
$13,620,000
$13,558,000
Gross Profit
10,819,000
11,514,000
10,393,000
10,234,000
EBITDA
5,841,000
6,076,000
5,831,000
5,188,000
EBIT
4,477,000
4,820,000
4,677,000
3,560,000
Net Income
3,928,000
4,041,000
3,606,000
2,818,000
Net Change In Cash
14,358,000
14,836,000
13,620,000
13,558,000
Free Cash Flow
5,740,000
6,106,000
2,151,000
3,062,000
Cash
9,556,000
6,656,000
7,066,000
11,459,000
Basic Shares
1,940,000
1,960,000
1,979,000
2,004,000

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$51,722,000
$46,660,000
$43,461,000
$43,974,000
Gross Profit
38,895,000
34,188,000
31,879,000
32,239,000
EBITDA
20,715,000
18,255,000
14,682,000
30,914,000
EBIT
14,646,000
9,978,000
7,977,000
25,317,000
Net Income
11,941,000
14,850,000
6,955,000
24,021,000
Net Change In Cash
51,722,000
46,660,000
43,461,000
43,974,000
Free Cash Flow
13,805,000
11,705,000
11,565,000
12,100,000
Cash
11,459,000
13,393,000
7,517,000
12,407,000
Basic Shares
2,035,000
2,092,000
2,197,000
2,260,000

Earnings Calls

QuarterEPS
2025-09-30
$2.25
2025-06-30
$2.42
2025-03-31
$2.28
2024-12-31
$1.98